To rapidly transfer its research results from bench to bedside, IFOM relies on both the Experimental Therapeutics Program to develop drug candidates and the Technology Transfer Office to forge partnerships with the pharmaceutical industry and venture capital funds to develop and commercialize products and services that can have a positive impact on patients.
The IFOM Technology Transfer Office is in charge of identifying and protecting IFOM’s most promising results for industrial applications deriving from its research programs, and of finding suitable partners for further development through:
Furthermore, the Technology Transfer Office encourages interactions of IFOM researchers with companies and provides education and advice to IFOM researchers who are interested in translating their inventions into innovations for the benefit of patients.
The IFOM Technology Transfer Office team consists of:
Francesco Grillo, Intellectual Property Manager
If you want to learn more about IFOM research programs and explore research collaboration and licensing opportunities, please contact us at tto-team[@]ifom.eu .